120 related articles for article (PubMed ID: 36712704)
1. Autosomal Dominant Vitreoretinochoroidopathy With a Novel BEST1 Mutation and a Review of Reported Mutations.
Komro J; Skender S; Ross BX; Lin X
Cureus; 2022 Dec; 14(12):e32990. PubMed ID: 36712704
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Macular Changes in the First Proband of Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) Due to a Newly Identified Mutation in BEST1.
Chen CJ; Kaufman S; Packo K; Stöhr H; Weber BH; Goldberg MF
Ophthalmic Genet; 2016; 37(1):102-8. PubMed ID: 26849243
[TBL] [Abstract][Full Text] [Related]
3. A novel missense mutation in BEST1 associated with an autosomal-dominant vitreoretinochoroidopathy (ADVIRC) phenotype.
Mano F; LoBue SA; Olsen TW; Marmorstein AD; Pulido JS
Ophthalmic Genet; 2018 Dec; 39(6):749-753. PubMed ID: 30222024
[TBL] [Abstract][Full Text] [Related]
4. Fundus Autofluorescence and SD-OCT Document Rapid Progression in Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) Associated with a c.256G > A Mutation in BEST1.
Kellner S; Stöhr H; Fiebig B; Weinitz S; Farmand G; Kellner U; Weber BH
Ophthalmic Genet; 2016 Jun; 37(2):201-8. PubMed ID: 26771239
[TBL] [Abstract][Full Text] [Related]
5. Mislocalisation of BEST1 in iPSC-derived retinal pigment epithelial cells from a family with autosomal dominant vitreoretinochoroidopathy (ADVIRC).
Carter DA; Smart MJ; Letton WV; Ramsden CM; Nommiste B; Chen LL; Fynes K; Muthiah MN; Goh P; Lane A; Powner MB; Webster AR; da Cruz L; Moore AT; Coffey PJ; Carr AF
Sci Rep; 2016 Sep; 6():33792. PubMed ID: 27653836
[TBL] [Abstract][Full Text] [Related]
6. Variable expressivity of
da Palma MM; Vargas ME; Burr A; Chen R; Pennesi ME; Weleber RG; Yang P
BMJ Open Ophthalmol; 2021; 6(1):e000813. PubMed ID: 34746433
[TBL] [Abstract][Full Text] [Related]
7. BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies.
Vincent A; McAlister C; Vandenhoven C; Héon E
Eye (Lond); 2011 Jan; 25(1):113-8. PubMed ID: 21072067
[TBL] [Abstract][Full Text] [Related]
8. Progressive Cone Dysfunction and Geographic Atrophy of the Macula in Late Stage Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC).
Chen CJ; Goldberg MF
Ophthalmic Genet; 2016; 37(1):81-5. PubMed ID: 24564716
[TBL] [Abstract][Full Text] [Related]
9. Ocular Histopathology and Immunohistochemical Analysis in the Oldest Known Individual with Autosomal Dominant Vitreoretinochoroidopathy.
Goldberg MF; McLeod S; Tso M; Packo K; Edwards M; Bhutto IA; Baldeosingh R; Eberhart C; Weber BHF; Lutty GA
Ophthalmol Retina; 2018 Apr; 2(4):360-378. PubMed ID: 29774302
[TBL] [Abstract][Full Text] [Related]
10. Comment: A novel missense mutation in BEST1 associated with an autosomal-dominant vitreoretinochoroidopathy (ADVIRC) phenotype.
Weisschuh N
Ophthalmic Genet; 2019 Feb; 40(1):87. PubMed ID: 30632872
[No Abstract] [Full Text] [Related]
11. Response to Weisschuh's "Comment: a novel missense mutation in BEST1 associated with an autosomal-dominant vitreoretinochoroidopathy (ADVIRC) phenotype".
Mano F; Pfannkoch C; LoBue SA; Olsen TW; Marmorstein AD; Pulido JS
Ophthalmic Genet; 2019 Feb; 40(1):88-89. PubMed ID: 30632873
[No Abstract] [Full Text] [Related]
12. ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing.
Burgess R; MacLaren RE; Davidson AE; Urquhart JE; Holder GE; Robson AG; Moore AT; Keefe RO; Black GC; Manson FD
J Med Genet; 2009 Sep; 46(9):620-5. PubMed ID: 18611979
[TBL] [Abstract][Full Text] [Related]
13. Autosomal dominant Best disease with an unusual electrooculographic light rise and risk of angle-closure glaucoma: a clinical and molecular genetic study.
Low S; Davidson AE; Holder GE; Hogg CR; Bhattacharya SS; Black GC; Foster PJ; Webster AR
Mol Vis; 2011; 17():2272-82. PubMed ID: 21921978
[TBL] [Abstract][Full Text] [Related]
14. Retinitis pigmentosa associated with a mutation in BEST1.
Dalvin LA; Abou Chehade JE; Chiang J; Fuchs J; Iezzi R; Marmorstein AD
Am J Ophthalmol Case Rep; 2016 Jul; 2():11-17. PubMed ID: 29503890
[TBL] [Abstract][Full Text] [Related]
15. Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies.
Nachtigal AL; Milenkovic A; Brandl C; Schulz HL; Duerr LMJ; Lang GE; Reiff C; Herrmann P; Kellner U; Weber BHF
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111077
[TBL] [Abstract][Full Text] [Related]
16. BESTROPHINOPATHY: A Spectrum of Ocular Abnormalities Caused by the c.614T>C Mutation in the BEST1 Gene.
Toto L; Boon CJ; Di Antonio L; Battaglia Parodi M; Mastropasqua R; Antonucci I; Stuppia L; Mastropasqua L
Retina; 2016 Aug; 36(8):1586-95. PubMed ID: 26716959
[TBL] [Abstract][Full Text] [Related]
17. Astrocytic hamartoma in a patient heterozygous for
Chiou YR; Cheng HC; Wang AG
Ophthalmic Genet; 2022 Jun; 43(3):409-412. PubMed ID: 35014575
[TBL] [Abstract][Full Text] [Related]
18. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of macular structure and function by OCT and electrophysiology in patients with vitelliform macular dystrophy due to mutations in BEST1.
Schatz P; Bitner H; Sander B; Holfort S; Andreasson S; Larsen M; Sharon D
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4754-65. PubMed ID: 20375334
[TBL] [Abstract][Full Text] [Related]
20. AUTOSOMAL DOMINANT VITREORETINOCHOROIDOPATHY: When Molecular Genetic Testing Helps Clinical Diagnosis.
Boulanger-Scemama E; Sahel JA; Mohand-Said S; Antonio A; Condroyer C; Zeitz C; Audo I
Retina; 2019 May; 39(5):867-878. PubMed ID: 29370033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
